Different roles for anti-cyclic citrullinated peptide antibodies and CD4+CD28null cells in the acceleration of atherosclerosis in rheumatoid arthritis: Comment on the article by Farragher et al

Arthritis and Rheumatism

Volumn 60, Issue 2, 2009, Pages 631-632

  Gerli, Roberto ^a   Vaudo, Gaetano ^a   Bocci, Elena Bartoloni ^a   Schillaci, Giuseppe ^a   Bistoni, Onelia ^a   Shoenfeld, Yehuda ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CELL EXPANSION; CELLULAR IMMUNITY; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; T LYMPHOCYTE SUBPOPULATION;

ALLELES; ANTIGENS, CD28; ANTIGENS, CD4; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; LYMPHOCYTES, NULL; PEPTIDES, CYCLIC; T-LYMPHOCYTE SUBSETS;

EID: 59649111932     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24297     Document Type: Letter

References (7)

1. Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D, et al. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008;58:359-69.
2. Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum 2004;50:400-12.
3. Berglin E, Padyukov L, Sundin U, Hallmans G, Stenlund H, Van Venrooij WJ, et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 2004;6:R303-8.
4. Gerli R, Bartoloni Bocci E, Sherer Y, Vaudo G, Moscatelli S, Shoenfeld Y. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:724-5.
5. Goronzy JJ, Weyand CM. Rheumatoid arthritis. Immunol Rev 2005;204:55-73.
6. Gerli R, Schillaci G, Giordano A, Bartoloni Bocci E, Bistoni O, Vaudo G, et al. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004;109:2744-8.
7. null T cells in rheumatoid arthritis. Arthritis Res Ther 2007;9:R87.